SCHEMBL24352145

SCHEMBL24352145

O=C(Cc1ccc(Cl)cc1)N1CCOCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.72
MAPT P10636 1/20 0.68
FAAH O00519 1/20 0.67
ALDH1A1 P00352 1/20 0.67
MGLL Q99685 1/20 0.67
GFER P55789 1/20 0.64
ATM Q13315 1/20 0.64
ME2 P23368 1/20 0.62
ME1 P48163 1/20 0.62
ME3 Q16798 1/20 0.62
FKBP1A P62942 1/20 0.61
AKR1C3 P42330 1/20 0.61
MEN1 O00255 1/20 0.61
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
PHGDH O43175 1/20 0.58
HTT P42858 1/20 0.57
USP2 O75604 1/20 0.57
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7430480 0.84 HPGD (0.67) KMT2AMAPTALDH1A1GFERATM
SCHEMBL9557082 0.84 FKBP1A (0.72) KMT2AMAPTFAAHALDH1A1MGLL
SCHEMBL26546711 0.83 SMN1; SMN2 (0.57) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL15650184 0.83 MAPT (0.68) KMT2AMAPTALDH1A1FKBP1AHTT
SCHEMBL5257247 0.83 MAPT (0.68) KMT2AMAPTFKBP1AAKR1C3PHGDH
SCHEMBL10174349 0.83 MAPT (0.68) KMT2AMAPTFAAHALDH1A1MGLL
SCHEMBL2798761 0.83 L3MBTL1 (0.72) KMT2AMAPTALDH1A1MEN1HTT
SCHEMBL9528958 0.83 HPGD (0.70) KMT2AMAPTALDH1A1GFERATM
SCHEMBL1516144 0.83 MAPT (0.82) KMT2AMAPTALDH1A1ME2ME1
SCHEMBL8704220 0.83 ALDH1A1 (0.61) KMT2AMAPTFAAHALDH1A1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220111367-A1 HYDROGENATION CATALYST FOR USE IN HYDROGENATING AMIDE COMPOUND AND METHOD FOR PRODUCING AMINE COMPOUND USING SAME OSAKA UNIVERSITY (JP) 2022-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220111367-A1 HYDROGENATION CATALYST FOR USE IN HYDROGENATING AMIDE COMPOUND AND METHOD FOR PRODUCING AMINE COMPOUND USING SAME SUV39H2, SUV39H1, HRH3 KMT2A 145/4885MAPT 1731/4885FAAH 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.